Phase II Study Of E7389, Halichondrin B Analogue, In Patients With Advanced Non-Small Cell Lung Cancer, NSCLC, Who Progressed During Or After Platinum-Based Doublet Chemotherapy

Clinical trial NCT00100932 · COMPLETED

Trial details

NCT number: NCT00100932
Sponsor: Eisai Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Non-Small-Cell Lung Carcinoma

Start date: 2004-12-01
Primary completion: 2008-06-01
Enrollment: 106

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.